Recurrent Small Cell Lung Cancer (SCLC)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Recurrent Small Cell Lung Cancer / Refractory Small cell lung cancer / Small Cell Lung Cancer Recurrent

Drug	Drug Name	Drug Description
DB01229	Paclitaxel	A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.

Drug	Drug Name	Target	Type
DB01229	Paclitaxel	Apoptosis regulator Bcl-2	target
DB01229	Paclitaxel	Tubulin beta-1 chain	target
DB01229	Paclitaxel	Cytochrome P450 2C8	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A4	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A5	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A7	enzyme
DB01229	Paclitaxel	Bile salt export pump	transporter
DB01229	Paclitaxel	P-glycoprotein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 7	transporter
DB01229	Paclitaxel	Cytochrome P450 19A1	enzyme
DB01229	Paclitaxel	Cytochrome P450 1B1	enzyme
DB01229	Paclitaxel	Solute carrier organic anion transporter family member 1B3	transporter
DB01229	Paclitaxel	Nuclear receptor subfamily 1 group I member 2	target
DB01229	Paclitaxel	Microtubule-associated protein 4	target
DB01229	Paclitaxel	Microtubule-associated protein 2	target
DB01229	Paclitaxel	Microtubule-associated protein tau	target
DB01229	Paclitaxel	Canalicular multispecific organic anion transporter 1	transporter

Drug	Drug Name	Phase	Status	Count
DB01933	7-Hydroxystaurosporine	1	Completed	1
DB12109	CPI-613	1	Completed	1
DB01248	Docetaxel	1	Terminated	1
DB15631	Edodekin alfa	1	Completed	1
DB00762	Irinotecan	1	Completed	1
DB00166	Lipoic acid	1	Completed	1
DB14123	Menthol	1	Completed	1
DB15721	Natural Killer Cell	1	Completed	1
DB00184	Nicotine	1	Completed	1
DB01229	Paclitaxel	1	Completed	1
DB11870	RG-4733	1	Terminated	1
DB00020	Sargramostim	1	Terminated	1
DB00877	Sirolimus	1	Completed	1
DB06287	Temsirolimus	1	Completed	1
DB00072	Trastuzumab	1	Completed	1
DB00361	Vinorelbine	1	Completed	1
DB06186	Ipilimumab	1 / 2	Recruiting	1
DB12674	Lurbinectedin	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB12191	Obatoclax	1 / 2	Completed	1
DB13017	Rovalpituzumab tesirine	1 / 2	Completed	1
DB01030	Topotecan	1 / 2	Completed	1
DB01933	7-Hydroxystaurosporine	2	Completed	1
DB08885	Aflibercept	2	Completed	1
DB11885	Anlotinib	2	Recruiting	2
DB11595	Atezolizumab	2	Recruiting	1
DB06362	Becatecarin	2	Terminated	1
DB06769	Bendamustine	2	Unknown Status	1
DB00112	Bevacizumab	2	Completed	1
DB04690	Camptothecin	2	Terminated	1
DB00958	Carboplatin	2	Completed	1
DB01254	Dasatinib	2	Completed	1
DB14951	Etirinotecan pegol	2	Completed	1
DB00773	Etoposide	2	Completed	1
DB13044	Gossypol	2	Completed	1
DB05899	IT-101	2	Terminated	1
DB00619	Imatinib	2	Completed	1
DB00762	Irinotecan	2	Completed	1
DB05707	Isosorbide	2	Completed	1
DB00331	Metformin	2	Recruiting	1
DB15299	Navtemadlin	2	Not Yet Recruiting	1
DB09079	Nintedanib	2	Completed	1
DB06300	Ponatinib	2	Active Not Recruiting	1
DB08901	Ponatinib	2	Active Not Recruiting	1
DB14729	Rebeccamycin	2	Terminated	1
DB06176	Romidepsin	2	Completed	2
DB11805	Saracatinib	2	Completed	1
DB15765	Sintilimab	2	Recruiting	1
DB00398	Sorafenib	2	Completed	1
DB00853	Temozolomide	2	Terminated	1
DB01030	Topotecan	2	Completed	3
DB01030	Topotecan	2	Terminated	1
DB00135	Tyrosine	2	Active Not Recruiting	1